share_log
Breakings ·  Jun 4 20:44
Under the sponsorship research agreement, Silo Pharma will be granted an exclusive license for global development and commercialization of Spc-15.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment